Skip to main content
SpringerLink
Log in

Sonstige Systembeteiligung des Bindegewebes (M 35)

  • Chapter
Interdisziplinäre klinische Rheumatologie

Auszug

Die erste Beschreibung der Erkrankung geht auf Mikulicz im Jahr 1888 zurück. 1933 fasste der schwedische Ophthalmologe Henrik Sjögren in einer Monographie 19 Patienten mit typischer Keratoconjunctivitis sicca und Xerostomie sowie systemischen Manifestationen zusammen. Differenzial diagnostische Erfordernisse in der Einordnung einer Sicca-Symptomatik mit verbesserten Einstichten in die pathogenese und Möglichkeiten der Diagnostik haben wesentlich für die Erkennung des Sjögren-Syndroms und zur Abgrenzung einer Vielzahl von Erkrankungen ohne autoimmune Groundlage beigetragen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur Literatur zu Kap.61.1

  • Dörner T (1998) Ätiologische und immunpathogenetische Aspekte des Sjögren-Syndroms. Akt Rheumatol 23: 69–77

    Google Scholar 

  • Dörner T, Hiepe F (1993) Zu aktuellen klinisch-immunologischen Aspekten des Sjögren-Syndroms. Z Ärztl Fortbild 87: 279–286

    Google Scholar 

  • Fox RI (1992) Treatment of the patient with Sjögren’s syndrome. Rheum Dis Clin North Am 18: 699–711

    PubMed  CAS  Google Scholar 

  • Fox RI (1996) Clinical features, pathogenesis, and treatment of Sjögren’s syndrome. Curr Opinion Rheumatol 8: 438–445

    Article  CAS  Google Scholar 

  • Fox RI, Maruyama T (1997) Pathogenesis and treatment of Sjögren’s syndrome. Curr Opinion Rheumatol 9: 393–399

    Article  CAS  Google Scholar 

  • Hansen A et al. (2002) Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren’s syndrome. Arthritis Rheum 46; 8: 2160–2171

    Article  PubMed  CAS  Google Scholar 

  • Hansen A et al. (2003a) Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjogren’s syndrome. Scand J Immunol 57; 5: 470–479

    Article  PubMed  CAS  Google Scholar 

  • Hansen A, Lipsky PE, Dörner T (2003b) New concepts in the pathogenesis of Sjogren syndrome many questions fewer answers. Curr Opin Rheumatol 15; 5: 563–570

    Article  PubMed  Google Scholar 

  • Hansen A et al. (2004) Abnormalities in peripheral B cell memory of patients with primary Sjogren’s Syndrome. Arthritis Rheum 50; 6: 1897–1908

    Article  PubMed  CAS  Google Scholar 

  • Hansen A, Lipsky PE, Dörner T (2005) Immunopathogenesis of primary Sjogren’s syndrome: implications for disease management and therapy. Curr Opin Rheumatol 17; 5: 558–565

    Article  PubMed  CAS  Google Scholar 

  • Manthorpe R (2002) Sjogren’s syndrome criteria. Ann Rheum Dis 61; 6: 482–484

    Article  PubMed  CAS  Google Scholar 

  • Moutsopoulos HM, Manoussakis MN (1998) Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjogren’s syndrome. Br J Rheumatol 37; 12: 1263–1264

    Article  PubMed  CAS  Google Scholar 

  • Pijpe J et al. (2005) Rituximab treatment in patients with primary Sjogren’s syndrome. Arthritis Rheum 52; 9: 2740–50

    Article  PubMed  CAS  Google Scholar 

  • Stathopoulou EA, et al. (2005) Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 28 protein. Clin Exp Immunol 141; 1: 148–154

    Article  PubMed  CAS  Google Scholar 

  • Vitali C et al. (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554–558

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kap. 61.2

  • Alarcón-Segovia D, Villareal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Elsevier, Amsterdam, pp 33–40

    Google Scholar 

  • Amigues JM, Cantagrel A, Abbal M, Mazieres B (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. J Rheumatol 23: 2055–2062

    PubMed  CAS  Google Scholar 

  • Aringer M, Steinei G, Smolen JS (2005) Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am 31: 411–420

    Article  Google Scholar 

  • Galie N, Ghofrani HA, Torbicki A et al. (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353: 2148–2157

    Article  PubMed  CAS  Google Scholar 

  • Kahn MF, Appelboom T (1991) Syndrome de Sharp. In: Kahn MF, Peltier AP, Meyer O, Piette JC (eds) Les maladies systémiques, 3ème edn. Flammarion, Paris, pp 545–556 Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease and anti-nuclear Antibodies. Elsevier, Amsterdam, pp 41–68

    Google Scholar 

  • Kim P, Grossman JM (2005) Treatment of mixed connective tissue disease. Rheum Dis Clin North Am 31: 549–565

    Article  PubMed  Google Scholar 

  • Korn JH, Mayes M, Matucci Cerinic M et al. (2004) Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, on oral endothelin receptor antagonist. Arthritis Rheum 50: 3985–3993

    Article  PubMed  CAS  Google Scholar 

  • Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nation-wide collaborative study in Japan. J Rheumatol 23: 1088–1094

    PubMed  CAS  Google Scholar 

  • Lundberg IE (2005) The prognosis of mixed connective tissue disease. Rheum Dis clin North Am 31: 535–547

    Article  PubMed  Google Scholar 

  • Magro CM, Crowson AN, Regauer S (1997) Mixed connective tissue disease. A clinical, histologic, and immunofluorescenc study of eight cases. Am J Dermatopathol 19: 206–213

    Article  PubMed  CAS  Google Scholar 

  • Michels H (1997) Course of mixed connective tissue disease in children Ann Med 29: 359–364

    Article  PubMed  CAS  Google Scholar 

  • Riemekasten G, Schulze-Koops H (2005) Medikamentöse vasoaktive Therapien von Mikrozirkulationsstörungen bei rheumatischen Erkrankungen. Z Rheumatol 64: 123–136

    Article  PubMed  CAS  Google Scholar 

  • Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific extractable nuclear antigen. Am J Med 52: 148–159

    Article  PubMed  CAS  Google Scholar 

  • Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Elsevier, Amsterdam, pp 23–32

    Google Scholar 

Literatur zu Kap. 61.3.

  • International study group for Behçet’s disease (1992) Diagnostic criteria for Behçet’s disease. Br J Rheumatol 31: 299–308

    Article  Google Scholar 

  • Kötter I, Gunaydin I, Zierhut M, Stubiger N (2004) The use of interferon alpha in Behçet disease: a review of the literature. Semin Arthritis Rheum 33: 320–335

    Article  PubMed  CAS  Google Scholar 

  • Kural-Seyahi E, Fresko I, Seyahi N et al. (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82: 60–76

    Article  PubMed  Google Scholar 

  • Lin P, Liang G (2006) Behçet disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12: 282–286

    Article  PubMed  Google Scholar 

  • Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C (2006) New approaches in the treatment of Adamantiades-Behçet’s disease. Curr Opin Rheumatol 18: 3–9

    Article  PubMed  CAS  Google Scholar 

  • Sahin M, Yildiz M, Tunc SE (2006) The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet’s disease. Ann Nucl Med 20: 649–653

    Article  PubMed  Google Scholar 

  • Van Laar JAM, Missotten T, Van Daele PLA et al. (2007) Adalimumab: a new modality for Behçet disease? Ann Rheum Dis 66: 565–566

    Article  PubMed  CAS  Google Scholar 

  • Yurdakul S, Hamuryudan V, Yazici H (2004) Behçet syndrome. Curr Opin Rheumatol 16: 38–42

    Article  PubMed  Google Scholar 

Literatur zu Kap. 61.4

  • Cantini F, Niccoli L, Storri L et al. (2004) Are polymyalgia reumatica and giant cell arteriitis the same disease? Semin Arthritis Rheum 33/5: 294–301

    Article  Google Scholar 

  • Caporali R, Cimmino MA, Ferraccioli G et al. (2004) Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 141/7: 493–500

    Google Scholar 

  • Duhaut P, Bosshard S, Ducroix JP (2004) Is gieant cell arteriiitis an infectious disease? Biological and epidemiological evidence. Presse Med 33/19 pt 2: 1403–1408

    Article  Google Scholar 

  • Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 23/4: 624–628

    Google Scholar 

  • Helfgott SM, Kieval RI (1996) Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate. Arthritis Rheum 39/2: 304–307

    Article  Google Scholar 

  • Hoffman GS, Cid MC, Hellmann DB et al. (2002) A multicenter, randomized, doubleblind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46/5: 1309–1318

    Article  CAS  Google Scholar 

  • Hunder GG, Bloch DA, Michel BA et al. (1990) The American College of Rheumatology 1990 criteria for the dassification of giant cell arteritis. Arthritis Rheum 33/8: 1122–1128

    Google Scholar 

  • Kaiser H (1993) Polymyalgia rheumatica. Z Gerontol 26/1: 20–23

    Google Scholar 

  • Koski M (1992) Ultrasonographic evidence of synovitis in axial joints in patients with polymyalgia rheumatica. Br J Rheumatol 31/3: 201–203

    Article  Google Scholar 

  • Martinez-Taboada VM, Goronzy JJ, Weyand CM (1996) Clonall expanded CD8T cells in patients with polymyalgia rheumatica and giant cell arteritis. Clin Immunol Immunopathol 79/3: 263–270

    Article  Google Scholar 

  • Nüsslein H (1997) Medikamentöse Therapie-Polymyalgia rheumatica und Riesenzellarteriitis. In: Qualitätssicherung in der Rheumatologie. Steinkopff, Darmstadt

    Google Scholar 

  • Salvarani C, Gabriel S, Hunder GG (1996) Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report on nineteen cases. Arthritis Rheum 39/1: 73–80

    Article  Google Scholar 

  • Seyfarth B, Harten P, Loffler H (1996) Die Thrombozytose bei Polymyalgia rheumatica. Dtsch Med Wochenschr 11; 121/41: 1255–1260

    Google Scholar 

  • Vaith P (1997) Diagnostische Kriterien — Polymyalgia rheumatica und Riesenzellarteriitis. In: Qualitätssicherung in der Rheumatologie. Steinkopff, Darmstadt

    Google Scholar 

  • Weyand CM, Goronzy JJ (1995) Giant cell arteritis as an antigen-driven disease. Rheum Dis Clin North Am 21/4: 1027–1039

    Google Scholar 

Literatur zu Kap. 61.5

  • Crofford LJ (1994) Eosinophilic fasciitis and the eosinophilia-myalgia syndrome. In: Rheumatology. Mosby, St. Louis, pp 6: 29.1–29.10

    Google Scholar 

  • Freundlich B (1993) Eosinophilia-myalgia syndrome. In: Kelley / Harris / Ruddy / Sledge (eds) Textbook of rheumatology, 4th edn, vol 2

    Google Scholar 

  • Hertzman PA, Blevins WL, Mayer J (1990) Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. In: N Engl J Med 322: 869–873

    PubMed  CAS  Google Scholar 

  • Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17: 221–231

    Article  PubMed  CAS  Google Scholar 

  • Medsger TJ (1990) Tryptophan-induced eosinophilia-myalgia syndrome (editorial). N Engl J Med 322: 926–928

    PubMed  Google Scholar 

  • Moulton SJ, Kransdorf MJ, Ginsburg WW, Abril A, Persellin S (2005) Eosinophilic fasciitis: spectrum of MRI Wndings. Am J Roentgenol 184: 975–978

    Google Scholar 

  • Shulman LE (1975) Diffuse fasciitis with eosinophilia: A new syndrome? In: Trans Assoc Am Physicians 88: 70

    PubMed  CAS  Google Scholar 

  • Swygert LA, Maes EF, Sewell LE et al. (1990) Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA 264: 1698–1703

    Article  PubMed  CAS  Google Scholar 

  • Varga J, Kähäri VM (1997) Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 9: 562–570

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kap. 61.6

  • Enzinger FM, Weiss SW (1995) Fibromatoses. In: Enzinger FM, Weiss SW (eds) Soft tissue tumors. Mosby, St. Louis, pp 201–229

    Google Scholar 

Literatur zu Kap. 61.7

  • Khan GA, Lewis FI (1996) Recognizing Weber-Christian disease. Tenn Med 89: 468–449

    Google Scholar 

Literatur zu Kap. 61.8

Literatur zu Kap. 61.9

  • Asherson RA, Cervera R, de Groot PG et al. (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12: 530–534

    Article  PubMed  CAS  Google Scholar 

  • Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: on update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74: 1185–1190

    PubMed  CAS  Google Scholar 

  • Brey RL, Chapman J, Levine SR et al. (2003) Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 12: 508–513

    Article  PubMed  CAS  Google Scholar 

  • Crowther MA, Wisloff F (2005) Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis. Thromb Res 115: 3–8

    PubMed  CAS  Google Scholar 

  • D’Cruz DP (2006) Antiphospholipid (Hughes) Syndrome an overview. In: Hughes Syndrome, Khamashta MA (ed) Springer, Berlin Heidelberg New York London, pp 9–21

    Google Scholar 

  • Espinosa G, Bucciarelli S, Cervera R et al. (2004) Thrombotic microangiopathic haemolytic anemia and antiphospholipid antibodies, Ann Rheum Dis 63: 730–736

    Article  PubMed  CAS  Google Scholar 

  • Gromnica-Ihle E, Schößler W, Jahn M, Meise I (1995) The importance of the isotypes of the antiphospholipid antibodies and of the anti-2-Glycoprotein I antibodies for the clinic. Lupus 4 (Suppl 2): 152 (Abstract)

    Google Scholar 

  • Khamashta MA (1996) Management of thrombosis in the antiphospholipid syndrome. Lupus 5: 463–466

    PubMed  CAS  Google Scholar 

  • Khamashta MA, Hunt BJ (2005) M oderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No. J Thromb Haemost 3: 844–845

    Article  CAS  Google Scholar 

  • Lima F, Khamashta MA, Buchanan NMM et al. (1996) A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14: 131–136

    PubMed  CAS  Google Scholar 

  • Miyakis S, Lockshin MD, Arsumi T et al. (2006) International consensus statement on an update of the classification criteria for definite aniphospholipid syndrome (APS). J Thromb Haemost 4: 295–306

    Article  PubMed  CAS  Google Scholar 

  • Reber G, Tincani A, Sanmarco M et al. (2004) Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2: 1860–1862

    Article  PubMed  CAS  Google Scholar 

  • Stone S, Khamashta MA, Poston L (2001) Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10: 67–74

    Article  PubMed  CAS  Google Scholar 

  • Wilson WA, Gharavi AE, Koike T et al. (1999) International consensus statement on preliminary classification criteria for definitive antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309–1311

    Article  PubMed  CAS  Google Scholar 

  • Wisloff F, Jacobson EM, Liestol S (2002) laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 108: 263–271

    Article  PubMed  CAS  Google Scholar 

Literatur zu Kap. 61.10

  • Alarcón GS, Williams GV, Singer JZ et al. (1991) Early undifferentiated connective tissue disease. I: Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 18: 1332–1339

    PubMed  Google Scholar 

  • Alarcón GS, Willkens RF, Ward JR et al. (1996) Early undifferentiated connective tissue disease. IV: Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum 39: 403–414

    Article  PubMed  Google Scholar 

  • Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S (1998) Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 7: 95–100

    Article  PubMed  CAS  Google Scholar 

  • Mosca M, Neri R, Bombardieri S (1999) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17: 615–620

    PubMed  CAS  Google Scholar 

  • Mosca M, Tani C, Neri C, Baldini C, Bombardieri S (2006) Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 6: 1–4

    Article  PubMed  CAS  Google Scholar 

  • Venables PJ (1998) Undifferentiated connective tissue diseases: mixed or muddled? Lupus 7: 73–74

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum Augustenburger Platz 1, 3353, Berlin

    T. Dörner Prof. Dr.

  2. Rheumapraxis, Villa am Krankenhaus Maria Heimsuchung, Breite Str. 46/47, 13187, Berlin

    E. Gromnica-Ihle Prof. Dr.

  3. Privatpraxis für Rheumatologie, Rheumatherapiezentrum Nürnberg Schweinauer, Hauptstr. 12, 90441, Nürnberg

    B. Lang Prof. Dr.

  4. Rheumatologikum, Rathenaustraße 13/14, 30159, Hannover

    H. Zeidler Prof. Dr.

  5. Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité-Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin

    F. Buttgereit Prof. Dr.

  6. Praxis für Rheumatologie, Marienstr. 27, 90402, Nürnberg

    H. Nüßlein Prof. Dr.

  7. Klinik und Poliklinik für Dermatologie, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden

    M. Meurer Prof. Dr.

  8. Evangelisches Krankenhaus Oldenburg, Steinweg 13-17, 26122, Oldenburg

    M. Schwarz-Eywill Dr.

  9. Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsklinikum Charité Med. Fakultät, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin

    F. Hiepe Prof. Dr.

Authors
  1. T. Dörner Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Gromnica-Ihle Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Lang Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Zeidler Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Buttgereit Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Nüßlein Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Meurer Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Schwarz-Eywill Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. F. Hiepe Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rheumatologikum, Rathenaustraße 13/14, 30159, Hannover

    Henning Zeidler

  2. Klinik für Orthopädie und orthopädische Rheumatologie, HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125, Berlin

    Josef Zacher

  3. Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsklinikum Charité Med. Fakultät, Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin

    Falk Hiepe

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Dörner, T. et al. (2008). Sonstige Systembeteiligung des Bindegewebes (M 35). In: Zeidler, H., Zacher, J., Hiepe, F. (eds) Interdisziplinäre klinische Rheumatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34105-5_61

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34105-5_61

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34104-8

  • Online ISBN: 978-3-540-34105-5

Publish with us

Policies and ethics

Search

Navigation